Major Depression: A Short Term Naturalistic Study in Outpatients
|
|
- Lindsay Robinson
- 8 years ago
- Views:
Transcription
1 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 APRIL 2011 Original Article 70 Major Depression: A Short Term Naturalistic Study in Outpatients Introduction Madhusudan*, Vankar GK**, Brahmbhatt M**, Rastogi R*, Verma P* *Department of Psychiatry Safdarjung Hospital & VMMC **Department of Psychiatry BJMC & Civil Hospital Ahmedabad Major depressive disorder is the most common disabling treatable condition diagnosed in psychiatric and primary care settings. WHO has ranked depression fourth in a list of most urgent health problem worldwide. hence studying its presentation, course, treatment response and outcome becomes important. 1-3 Treatment response and outcome often differs in Naturalistic conditions than controlled trials. Many Naturalistic studies in various parts of the world have explored course and outcome of major depressive disorder, envisaging on one hand studying its early course to subjects followed up years together being treated in natural clinical settings. 4-6 Surprisingly there are no ABSTRACT Background: Surprisingly data regarding naturalistic or observational studies carried out in India to study Major Depressive Disorder in patients seeking outpatient treatment is almost non-existing. So this study was conducted to study the presentation and baseline characteristics of Major Depressive Disorder in Indian outpatients and the subsequent treatment and outcome after a three month follow up. Methodology: Patients seeking outpatient treatment were recruited after diagnosing an episode of Major Depressive Disorder through a clinical interview for DSM IV TR. Sociodemographic and clinical characteristics were recorded at the time of recruitment and follow up evaluations done for 3 months. All the patients were given outpatient treatment best suited to the patient profile. Results :.More than 90% patients reported one or more somatic symptoms spontaneously on presentation. Barely half of the patients out of 119 recruited completed three month follow up. 50 (81%) patients out of 62 who received adequate treatment met recovery criteria at the end of three months. Initial depression severity and receiving regular adequate antidepressant therapy was found to be associated with recovery. While sociodemographic variables were not found to significantly affect treatment outcome or compliance. Conclusion : Somatic presentation of depression is quite common in Indian patients.the high noncompliance indicate the need for strategies to be made to improve compliance and the good response to treatment found in naturalistic conditions in this study calls for more such studies to be done for better understanding of predictors of outcome in naturalistic conditions in India. Key Words: Major depression, naturalistic study, outpatients. published naturalistic studies in India on Major Depressive Disorder up to best of our knowledge. All this prompted us to take up this first of its kind study ever done with Indian depressed Outpatients. This study documents the presentation, early course and outcome of major depressive disorder in psychiatric outpatients treated in naturalistic conditions and sees whether intensive regular antidepressant therapy is associated with recovery. Materials and Methods Study was conducted at psychiatric OPD civil hospital Ahmedabad. Patients presenting with depression for the first time in psychiatric OPD seeking outpatient treatment were recruited. Written
2 APRIL 2011 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 informed consent was obtained prior to induction of subjects into the study. Patients were diagnosed as having Major depression by a clinical interview by psychiatry residents and consultants based on DSM-IV TR diagnostic criteria. 7 Exclusion criteria were depression secondary to schizophrenia and dementia, presence of psychotic symptoms, actively suicidal patient, comorbid general medical condition directly contributing to depression (eg hypothyroidism), comorbid substance use disorder or presence of bipolar disorder. A total of 119 patients were recruited over a period of 10 months. Baseline sociodemographic and clinical variables of each patient were recorded at the time of presentation. Severity of depression on presentation and subsequent follow ups was assessed using 24 item HDRS scale. 8 Patients were followed up to a period of 3 months with follow up evaluations and assessment of severity and treatment response done at 15 days, one month and at the end of three months. Each patient was given an antidepressant best suited to the patient profile; adequate treatment was defined as drug being given in therapeutic doses (eg. 20 mg fluoxetine, 150 mg Imipramine or equivalent.) with regular follow-ups for a period of three months. The absence of the above two was considered as inadequate treatment. The therapeutic doses were reached in 15 to 20 days. A score of 7 or less than 7 on HDRS was considered as remission. While greater than 50% reduction in initial symptoms score was considered as response. Data was analyzed and statistical tests were applied as appropriate. Two-tailed P values of less than.05 were considered statistically significant. Results 1. Socidemographic characteristics. A total of 119 depressed patients coming for the first time in psychiatric OPD seeking outpatient treatment were recruited. Age of patients ranged from 18 to 65(mean age = years). Around 48% of the patients were males and 52% were females. 87% had urban background while 13% were from rural areas. Almost 3/4th of the patients (76%) were married while 1/4th were single (unmarried, divorced, separated, and widowed). Majority of patients (66%) were employed either in skilled (27%) or unskilled jobs (39%), a good no of patients were housewives (28%) while only a few 7% were unemployed, retired or students. Around 18% of them were illiterate, only 13% had studied up to graduate level while the rest had education up to primary or high school level. Most of them (74%) had monthly income of Rupees 5000 or less. Half of the patients (50%) belonged to joint families. Depression severity at presentation: Clinical variables and symptomatic presentation If we look at the baseline severity then 54 % patients fell into the mild to moderate category, 29% were having severe depression while only 17% had Table-1. Depression Severity at Presentation Patients Mild Mod. depression Severe Very Severe depression HDRS score depression depression HDRS* score HDRS score HDRS score (8-13) (14-18) (19-22) (>23) 24(20)* 41(34) 34(29) 20(17) Patients with regular 3 12 (19) 20 (32) 21 (34) 9 (15) month fup= 62 Patient with irregular 1 (10) 5 (50) 2 (20) 2 (20) fup=10 Patient lost to fup =47 11 (23) 16 (34) 11 (23) 9 (19) * Data are given as number (percentage) of patients in the table. HDRS: Hamilton Depression Rating Scale. 71
3 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 APRIL 2011 Table-2a. Baseline Clinical Characteristics Descriptor Total no of Patients with Patient with Patient lost Stat. patients 3 month f up irregular f up to f up analysis (N = 119) (n = 62) ( n = 10) ( n= 47) Baseline HDRS (4.70) (4.83) (4.19) (4.73) ANOVA Scores, mean (SD)* p=0.971 Duration 2=.0038 < 6 month 96 (81) 50 (81) 8 (80) 38 (81) df=2p > 6 months 23 (19) 12 (19) 2 (20) 9 (19) =0.998 Past history of 2=1.956 depression 16 (13) 10 (62) 0 6 (13) df=2p Present Absent 103 (87) 52 (84) 10 (100) 41 (87) =0.376 Family history Nil 102 (80) 53 (85) 9 (90) 40 (85) 2=.1669 Positive for 8 (07) 4 (06) 0 4 (09) df=2p depression 3 (06) =0.919 Positive for any 9 (08) 5 (08) 1 (10) other psychiatric illness Psychosocial stressor 2=2.432 Present 76 (64) 36 (58) 6 (60) 34 (72) df=2 Absent 43 (36) 26 (42) 4 (40) 13 (28) p=0.296 *Data are given as mean (SD) in the upper row and given as number (percentage) of patients in the lower rows. HDRS: Hamilton Depression Rating Scale. very severe depression (table1). Majority of patients 63% were having duration of depression between 1 to 6 months, 18% had depressive symptoms for less than one month while 19% had duration greater than 6 months. Very few patients (13%) had past history of a depressive episode while only 7% had family history of depression (table 2a). One or mor e somatic symptoms (most commonly pain, heaviness in head, sleep disturbance, and decreased appetite) were at first spontaneously reported by 91 % of the patients when they presented while further inquiry revealed cognitive and emotional symptoms characteristic of depression. Among the depressive symptoms, sad mood (100%), lack of interest (98%), sleep disturbance (90%), and fatigue (90%) were the most commonly encountered symptoms (table2b). There was not found any significant difference between baseline Sociodemographic and Clinical variables of subjects with regular follow ups, irregular follow ups or those who were lost to follow up. Drop out rate was quite high and only 62 patients Table-2b. Symptom Presentation Symptoms % of patients Sad mood 100 Lack of interest 98 Sleep disturbance 90 Fatigue /LOE 90 Wt loss/red app 86 Worth/helpless 80 Forgetfulness 45 PMA/retardation 38 Death wishes 34 (52%) completed regular three month follow up, 10 patients ( 8%) came for irregular follow ups while 47 patients (39%) were lost to follow up. Presence or absence of psychosocial stressor was not found to be significantly associated with compliance. ( 2=2.432, df=2, p=0.296). Treatment given Majority of patients (74%) received an SSRI, 72
4 APRIL 2011 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 20% received a Tricyclic Antidepressant while only 4 patients were given both in succession, out of these 2 patients were shifted from a TCA to SSRI due to not tolerating the side effects of TCAs. There was not found any significant association between class of drug given and treatment compliance and response ( 2 =.899 df =2 p =.63). Comparison of recovered and non-recovered subjects. Out of the 62 patients completing regular three months follow up 50 subjects (81%) met recovery criteria, compared to only 2 subjects (20%) with irregular follow up and inadequate treatment. Thus remission was found to be significantly associated with intensive adequate pharmacotherapy. ( 2 =12.9, df=1, p=0.0001) Table-3a. Treatment response and outcome at the end of three months. Rx Regular Irregular response N=62 (%) N=10 (%) Remitted 50 (81) 2 (20) Partial recovery 7 (11) 0 (0) Non responders 5 (8) 8 (80) ( 2 =12.9, df=1, p=0.0001) In the 62 regular follow up patients, 7 patients (11%) did not meet recovery criteria but they met the criteria for response. 5 patients (8%) did not even show response at the end of three months assessment. Out of the 10 patients completing three-month irregular follow up with inadequate treatment only 2 patients (20%) met recovery criteria while 8 patients (80%) were still having significant depressive symptoms at the end of three months. On comparing the recovered and non-recovered subjects clinical variable of lower baseline HDRS scores was found to be significantly associated with recovery. (t = df = 61, p<0.0001). None of the sociodemographic variables was found to be associated with recovery or treatment response in patients who recovered or who did not recover. Similarly presence or absence of psychosocial stressor was not found to be significantly associated with recovery (p= 0.745) (table3b). Discussion Looking at the presentation we interestingly found that most patients with depression at first spontaneously reported one or more somatic symptoms (mostly pain, heaviness in head, sleep disturbance, decreased appetite) while typical depressive symptoms were revealed on further probing. This finding is in accordance with similar finding in Indian depressed patients reported previously by Weiss et al. 9 Somatic symptoms of vague aches and pains are extremely common in depression. In non-western cultures, most patients with depression present with somatic complaints. Many non-western cultures use somatic idioms for low mood and sadness, but detailed inquiry usually reveals cognitive and emotional symptoms typical of depression. 10 Although there is now growing evidence that somatic symptoms are common presenting features of depression throughout the world The reason for this somatic presentation of depression may be as it has been suggested previously that somatization is a concept that reflects the dualism inherent in Western biomedical practice, whereas in most of the great traditions of medicine (such as Chinese or ayurvedic medicine) a sharp distinction between the mental and the physical does not occur. 15 Similarly it has been said that people from traditional cultures may not distinguish between the emotions of anxiety, irritability and depression because they tend to express distress in somatic terms. 16 Compliance is a major problem in depression as in our study too 40% patients were lost to follow up while 8% came for irregular follow ups, this finding is in accordance with previous studies which have reported drop out rates of 30 to 60% in depressed out patients. 17,18 Similar findings have been reported previously by Lin et al. 19 that contrary to clinical practice guidelines for the treatment of depression, which recommend at least 6 to 9 months of continuous therapy, they found that 28% of patients discontinue antidepressant treatment within the first month of therapy, and more than 40% of patients discontinue this therapy by 3 months. In this study there was not found any significant association between class of drug (either SSRI or TCAs) given and treatment compliance and response as has been found previously by Song et al (1993). 20 There was not found any significant difference 73
5 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 APRIL 2011 Table-3b. Baseline clinical characteristics of recovered and non recovered subjects Descriptor Total no of Recovered Non t test df p value patients with patients recovered regular 3 patients month follow up(n=62) (n=50) (n=12) 24 item HDRS score 18.19(4.83) 17.74(4.90) 20.08(4.16) < mean (SD)* 2 df p value Duration <6 months 47 (76) 40 (80) 7 (58) >6 months 15 (24) 10 (20) 5 (42) Past history of depression Present 10 (16) 7 (14) 3 (25) Absent 52 (84) 43 (86) 9 (75) Family history Nil 55 (89) 44 (88) 11 (92) Fisher s p= 1.00 Positive for 4 (06) 3 (06) 1 (08) exact depression Positive for 3 (05) 3 (06) 0 any other psychiatric illness Psychosocial stressor Present 36 (58) 28 (56) 8 (67) Fisher s p= Absent 26 (42) 22 (44) 4 (33) exact, *Data are given as mean (SD) in the upper row and given as number (percentage) of patients in the lower rows. HDRS: Hamilton Depression Rating Scale between baseline Sociodemographic and Clinical variables of subjects with regular follow ups, irregular follow ups or those who were lost to follow 6, 21,22 up as has been reported previously also. Comparing the recovered and non-recovered patients we found that none of the sociodemographic variables including marital status or gender was found to be associated with recovery or treatment response in patients who recovered or who did not recover as has been found earlier also while some studies have found better recovery in females and married. 6,21,23-26, The finding in our study that presence or absence of psychosocial stressors was not found to be significantly associated with either recovery or compliance is in congruence with previous studies that have found that clinical variables are more significantly associated with outcome rather than psychosocial stressors but which stands in contrast to other studies that report recovery being affected negatively by the presence of psychosocial stressors 24,25, 34 In our study barely half of the patients were able to achieve the criteria for regular adequate pharmacotherapy and 81 % of them achieved the recovery criteria at the end of three months while various previous studies have found recovery in the range of 33% to 67% with 74
6 APRIL 2011 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 adequate pharmacotherapy The higher rates of recovery found in our study may be due to: 1. As the outcome was assessed up to three month only, it has been reported earlier also that rate of recovery is highest in first three month after start of treatment than later on. 31,32 2. Data should be interpreted in terms of the definition of recovery used. If the recovery criteria change the results could have been different. 33,34 3. Possible better coping of people belonging to lower socioeconomic class in India, though there is no published study in India to support this hypothesis but in a survey done in 1995 Blue et al. found that Indian women living in slums fared far better in mental health than the same population in Brazil and Chile. 35 A study done in severely depressed patients by Croughan et al (1988) found rate of recovery to be higher in those belonging to lower income group. 36 One finding that came out in our study is that subjects who had lower baseline HDRS scores recovered better than those who had higher baseline HDRS scores i.e. lower baseline HDRS scores are associated with recovery in naturalistic conditions corroborates similar finding previously by Barnett et al (2002). 6 Our study finds that regular intensive antidepressant therapy is associated with recovery in naturalistic conditions which is also in congruence with similar findings previously. 6 The finding that majority of patients seeking out regular treatment for major depression recovered within 3 months speaks to the need for regular adequate treatment. Limitation Majority of the patients belonged to lower socioeconomic strata and hence findings cannot be generalized unless similar studies are carried out involving patients from all sociocultural backgrounds. Conclusion The study finds and strengthens the earlier findings that depressed patients often present with somatic symptoms in India and hence diagnosing depression keeping this fact in mind will probably help clinicians in diagnosing depression correctly in Indian patients. Greater recovery with adequate treatment in clinical settings clearly indicates the importance of regular adequate pharmacotherapy. Looking at the high rate of noncompliance there is a need to make strategies to increase compliance. As the results found in the study are somewhat different from what efficacy trials of drugs and naturalistic studies have reported in the West, it calls for better understanding of predictors of outcome in naturalistic conditions in India. References 1. Kessler RC, Berglund P, Demler O. The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R); JAMA 2003; 289 : Lehtinen V, Joukamaa M. Epidemiology of depression: prevalence, risk factors and treatment situation, Acta Psychiatr Scand, Suppl. 1994; 377: Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause : Global Burden of Disease Study. Lancet 1997; 349: Doi: /S (96) Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, Fiester SJ, Parloff MB. National Institute of Mental Health Treatment of Depression Collaborative Research Program: general effectiveness of treatments. Arch Gen Psychiatry 1989; 46 : Malt UF, Robak OH, Madsu H-P, Bakke O, Loeb M. The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study. BMJ 1999; 318 : Barnett et al. Predictors of Early Recovery From Major Depression Among Persons Admitted to Community-Based Clinics; Arch Gen Psychiatry 2002; 59 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition TEXT REVISION. Washington, DC: American Psychiatric Association; Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23 : Weiss MG, Raguram R, Channabasavanna SM. 75
7 DELHI PSYCHIATRY JOURNAL Vol. 14 No.1 APRIL 2011 Cultural dimensions of psychiatric diagnosis. A comparison of DSM III R and illness explanatory models in south India. Br J Psychiatry 1995; 166 : Bhugra D, Ranjith G, Patel V, Affective Disorders in Handbook of Psychiatry: A South Asian Perspective 2005; (235). 11. Simon GE, Von Korff M, Piccinelli M. An international study of the relation between somatic symptoms and depression. New Engl J Med 1999; 341 : Bhatt A, Tomenson B, Benjamin S. Transcultural patterns of somatisation in primary care: a preliminary report. J Psychosom Res 1989; 33 : Ebert D, Martus P. Somatisation as a core symptom of melancholic type depression: evidence from a cross-cultural study. J Affect Disord 1994; 32 : Katon W, Walker EA. Medically unex-plained symptoms in primary care. J Clin Psychiatry 1998; 59 (suppl. 20) : Kirmayer LJ, Young A. Culture and somatization: clinical, epidemiological and ethnographic perspectives. Psychosom Med 1998; 60 : Leff JP. International variations in the diagnosis of psychiatric illness. Br J Psychiatry 1977; 131 : Demyttenaere K, Haddad P. Compliance with antidepressant therapy and antidepressant discontinuation symptoms, Acta Psychiatr Scand 2000; 101(S403) : Simon G, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993; 15: Lin EHB, VonKorff M, Katon W, Bush T, Simon GE, Walker E, Robinson P: The role of the primary care physician in patients adherence to antidepressant therapy. Med Care 1995; 33 : Song F, Freemantle N, Sheldon TA. Selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis of efficacy and acceptability. BMJ, 1993 ; 306 : Perlis RH, Alpert J, Nierenberg AA. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day, Acta Psychiatr Scand, 2007; 108 : Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B: Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288 : Psychosocial Predictors of Outcome in Depression: Robert M. A. Hirschfeld; Psychopharmacology: The Fourth Generation of Progress, GN /Default.htm. 24. Sergeant JK, Bruce ML, Florio LP, Weissman M. Factors associated with 1-year outcome of major depression in the community. Arch Gen Psychiatry 1990; 47 : Goodyer, Herbert, Joe Tamplin, Alison: Short- Term Outcome of Major Depression: II. Life Events, Family Dysfunction, and Friendship Difficulties as Predictors of Persistent Disorder. J Am Acad Child Adolesc Psychiatry 1997; 36 (4) : Spillmann M, Borus JS, Davidson KG, Worthington JJ III, Tedlow JR, Fava M. Sociodemographic predictors of response to antidepressant treatment. Int J Psychiatry Med 1997; 27 : RM Hirschfeld, GL Klerman, NC Andreasen : Psychosocial predictors of chronicity in depressed patients; Br J Psychiatry 1986; 148 : Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178 : Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002 ; 159 : Cuffel BJ, Azocar F, Tomlin M, Greenfield SF, Busch AB, Croghan TW. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 2003; 64 :
8 APRIL 2011 DELHI PSYCHIATRY JOURNAL Vol. 14 No Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J. Long-term outcome of episodes of major depression: clinical and public health significance. JAMA 1984; 252 : Keller MB, Shapiro RW, Lavori PW, Wolfe N. Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry 1982; 39 : Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM: Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991; 48 : Zimmerman M, Posternak MA, Chelminski I. Implications of using different cut-offs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 2004; 19 : Blue I, Ducci ME, Jaswal S. The mental health of low income urban women. In Urbanisation and Mental Health in Developing Countries (edst. Harpham and I. Blue), Aldershot: Avebury 1995; pp Croughan JL, Secunda SK, Katz MM. Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients. J Psychiatr Res 1988; 22 (3) :
Post Traumatic Stress Disorder (PTSD) Karen Elmore MD Robert K. Schneider MD Revised 5-11-2001 by Robert K. Schneider MD
Post Traumatic Stress Disorder (PTSD) Karen Elmore MD Robert K. Schneider MD Revised 5-11-2001 by Robert K. Schneider MD Definition and Criteria PTSD is unlike any other anxiety disorder. It requires that
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationUpdate on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice
Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological
More informationTREATING MAJOR DEPRESSIVE DISORDER
TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.
More informationDepression, Mental Health and Native American Youth
Depression, Mental Health and Native American Youth Aisha Mays, MD UCSF Department of Family And Community Medicine Native American Health Center Oakland, CA July 8, 2015 Presenter Disclosures No relationships
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,
More informationCLINICIAN INTERVIEW TREATING DEPRESSION IN THE PRIMARY CARE SETTING. Interview with J. Sloan Manning, MD
TREATING DEPRESSION IN THE PRIMARY CARE SETTING Interview with J. Sloan Manning, MD Dr J. Sloan Manning is the founding editor of the Primary Care Companion to the Journal of Clinical Psychiatry and a
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA MAJOR DEPRESSION IN ADULTS IN PRIMARY CARE HEALTH CARE GUIDELINE (ICSI) Health Care Guideline Twelfth Edition May 2009. The guideline was reviewed and adopted by the Molina
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationSerious Mental Illness: Symptoms, Treatment and Causes of Relapse
Serious Mental Illness: Symptoms, Treatment and Causes of Relapse Bipolar Disorder, Schizophrenia and Schizoaffective Disorder Symptoms and Prevalence of Bipolar Disorder Bipolar disorder, formerly known
More informationDepression in the Elderly: Recognition, Diagnosis, and Treatment
Depression in the Elderly: Recognition, Diagnosis, and Treatment LOUIS A. CANCELLARO, PhD, MD, EFAC Psych Professor Emeritus and Interim Chair ETSU Department of Psychiatry & Behavioral Sciences Diagnosis
More informationElizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller
Elizabeth A. Crocco, MD Assistant Clinical Professor Chief, Division of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Miller School of Medicine/University of Miami Question 1 You
More informationManaging depression after stroke. Presented by Maree Hackett
Managing depression after stroke Presented by Maree Hackett After stroke Physical changes We can see these Depression Emotionalism Anxiety Confusion Communication problems What is depression? Category
More informationMajor Depressive Disorder (MDD) Guideline Diagnostic Nomenclature for Clinical Depressive Conditions
Major Depressive Disorder Major Depressive Disorder (MDD) Guideline Diagnostic omenclature for Clinical Depressive Conditions Conditions Diagnostic Criteria Duration Major Depression 5 of the following
More informationDEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE
1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff
More informationin young people Management of depression in primary care Key recommendations: 1 Management
Management of depression in young people in primary care Key recommendations: 1 Management A young person with mild or moderate depression should typically be managed within primary care services A strength-based
More informationA STUDY OF APPLICABILITY OF HAMILTON DEPRESSION RATING SCALE IN A TERTIARY PSYCHIATRY CLINIC OF KOLKATA
ORIGINAL ARTICLE A STUDY OF APPLICABILITY OF HAMILTON DEPRESSION RATING SCALE IN A TERTIARY PSYCHIATRY CLINIC OF KOLKATA Ghosal Malay 1, Debnath Asish 2, Mondal Sukhendu 3, Chowdhary Ranadip 4, Mallik
More information(4) To characterize the course of illness after adequate response to and continuation on the treatments found effective for individual participants.
I. Specific Aims/Objectives STAR*D has several main objectives and is powered to assess the effectiveness of a sequence of treatments at various levels of treatment. Most of these objectives entail evaluating
More informationMOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION
MOH CLINICAL PRACTICE GUIDELINES 6/2011 DEPRESSION Executive summary of recommendations Details of recommendations can be found in the main text at the pages indicated. Clinical evaluation D The basic
More informationBest Practices Treatment Guideline for Major Depression
Best Practices Treatment Guideline for Major Depression Special Report on New Depression Treatment Technology Based on 2010 APA Practice Guidelines Best Practices Guideline for the Treatment of Patients
More informationCARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS
CARE MANAGEMENT FOR LATE LIFE DEPRESSION IN URBAN CHINESE PRIMARY CARE CLINICS Dept of Public Health Sciences February 6, 2015 Yeates Conwell, MD Dept of Psychiatry, University of Rochester Shulin Chen,
More informationTREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
More informationDepre r s e sio i n o i n i a dults Yousuf Al Farsi
Depression in adults Yousuf Al Farsi Objectives 1. Aetiology 2. Classification 3. Major depression 4. Screening 5. Differential diagnosis 6. Treatment approach 7. When to refer 8. Complication 9. Prognosis
More informationMental Health Referral Practices and Diabetic Management at Community Medical Alliance Clinic (Bell Site) Northeast Community Clinic (NECC)
Mental Health Referral Practices and Diabetic Management at Community Medical Alliance Clinic (Bell Site) Northeast Community Clinic (NECC) MaryAnn Garcia, SUNY Downstate Medical College NMF PCLP Scholar
More informationDepression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
More informationDepression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City
Depression and its Treatment in Older Adults Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City What is Depression? Everyday use of the word Clinically significant depressive symptoms : more severe,
More informationAlgorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
More informationDr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing
Dr. Anna M. Acee, EdD, ANP-BC, PMHNP-BC Long Island University, Heilbrunn School of Nursing Overview Depression is significantly higher among elderly adults receiving home healthcare, particularly among
More informationAlcohol Dependence Syndrome: One year outcome study
APRIL 2007 DELHI PSYCHIATRY JOURNAL Vol. 10 No.1 Original Article Alcohol Dependence Syndrome: One year outcome study Ajeet Sidana, Sachin Rai, B.S. Chavan Department of Psychiatry, Govt. Medical College
More informationPhysical symptoms are extremely prevalent in a primary
JGIM Blackwell Publishing, Ltd. ORIGINAL ARTICLES Volume 19, August 2004 The Outcome of Physical Symptoms with Treatment of Depression Teri Greco, MD, George Eckert, MAS, Kurt Kroenke, MD OBJECTIVE: This
More informationRecognizing and Treating Depression in Children and Adolescents.
Recognizing and Treating Depression in Children and Adolescents. KAREN KANDO, MD Division of Child and Adolescent Psychiatry Center for Neuroscience and Behavioral Medicine Phoenix Children s Hospital
More informationMedication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center
Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):
More informationAssessment of depression in adults in primary care
Assessment of depression in adults in primary care Adapted from: Identification of Common Mental Disorders and Management of Depression in Primary care. New Zealand Guidelines Group 1 The questions and
More informationCompliance with treatment for depression
7 Compliance with treatment for depression Patients views about taking medication for depression People with depression said that their attitudes to taking medication varied according to how they felt
More informationIMR ISSUES, DECISIONS AND RATIONALES The Final Determination was based on decisions for the disputed items/services set forth below:
Case Number: CM13-0018009 Date Assigned: 10/11/2013 Date of Injury: 06/11/2004 Decision Date: 01/13/2014 UR Denial Date: 08/16/2013 Priority: Standard Application Received: 08/29/2013 HOW THE IMR FINAL
More informationDepression Assessment & Treatment
Depressive Symptoms? Administer depression screening tool: PSC Depression Assessment & Treatment Yes Positive screen Safety Screen (see Appendix): Administer every visit Neglect/Abuse? Thoughts of hurting
More informationGeriatric Mood and Anxiety Disorders: 5 Things you need to know about Treating Depression in the Elderly
Geriatric Mood and Anxiety Disorders: 5 Things you need to know about Treating Depression in the Elderly Kiran Rabheru MD, CCFP, FRCP Geriatric Psychiatrist, The Ottawa Hospital Professor, University of
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More informationALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders
1 MH 12 ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders Background This case definition was developed by the Armed Forces Health Surveillance
More informationStep 4: Complex and severe depression in adults
Step 4: Complex and severe depression in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive
More informationHealth Anxiety and Hypochondriasis in Older Adults: Overlooked Conditions in a Susceptible Population
Health Anxiety and Hypochondriasis in Older Adults: Overlooked Conditions in a Susceptible Population Presented by: Renée El-Gabalawy, M.A., Ph.D Candidate Collaborators Dr. Corey Mackenzie Associate Professor
More informationNICE Clinical guideline 23
NICE Clinical guideline 23 Depression Management of depression in primary and secondary care Consultation on amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised
More informationALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders
1 MH 12 ALCOHOL RELATED DISORDERS Includes Alcohol Abuse and Alcohol Dependence; Does Not Include Alcohol Use Disorders Background This case definition was developed by the Armed Forces Health Surveillance
More information1. Which of the following SSRIs requires up to a 5-week washout period because of the
1 Chapter 38. Major Depressive Disorders, Self-Assessment Questions 1. Which of the following SSRIs requires up to a 5-week washout period because of the long half-life of its potent active metabolite?
More informationFrequent headache is defined as headaches 15 days/month and daily. Course of Frequent/Daily Headache in the General Population and in Medical Practice
DISEASE STATE REVIEW Course of Frequent/Daily Headache in the General Population and in Medical Practice Egilius L.H. Spierings, MD, PhD, Willem K.P. Mutsaerts, MSc Department of Neurology, Brigham and
More informationDiagnostic Boundaries of Bipolar Disorders. Terence A. Ketter, M.D.
Diagnostic Boundaries of Bipolar Disorders Terence A. Ketter, M.D. Disclosure Information Research Support / Consultant / Speaker Abbott Laboratories, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationAddiction Billing. Kimber Debelak, CMC, CMOM, CMIS Director, Recovery Pathways
Addiction Billing Kimber Debelak, CMC, CMOM, CMIS Director, Recovery Pathways Objectives Provide overview of addiction billing contrasting E&M vs. behavioral health codes Present system changes in ICD-9
More informationSome helpful reminders on depression in children and young people. Maria Moldavsky Consultant Child and Adolescent Psychiatrist
Some helpful reminders on depression in children and young people Maria Moldavsky Consultant Child and Adolescent Psychiatrist The clinical picture What art and my patients taught me Albert Durer (1471-1528)
More informationWhat happens to depressed adolescents? A beyondblue funded 3 9 year follow up study
What happens to depressed adolescents? A beyondblue funded 3 9 year follow up study Amanda Dudley, Bruce Tonge, Sarah Ford, Glenn Melvin, & Michael Gordon Centre for Developmental Psychiatry & Psychology
More informationPreferred Practice Guidelines for the Identification and Treatment of Depressive Disorder
Preferred Practice Guidelines for the Identification and Treatment of Depressive Disorder These Guidelines were based in part from on following: Treatment of Patients With Major Depressive Disorder from
More informationTreatment of Prescription Opioid Dependence
Treatment of Prescription Opioid Dependence Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse McLean Hospital, Belmont, MA Professor of Psychiatry, Harvard Medical School, Boston, MA Prescription
More informationSchizoaffective disorder
Schizoaffective disorder Dr.Varunee Mekareeya,M.D.,FRCPsychT Schizoaffective disorder is a psychiatric disorder that affects about 0.5 to 0.8 percent of the population. It is characterized by disordered
More informationTHE PREVALENCE AND OUTCOME OF PARTIAL REMISSION IN DEPRESSION
THE PREVALENCE AND OUTCOME OF PARTIAL REMISSION IN DEPRESSION David Healy, MD, FRCPsych, Reader in Psychological Medicine, University of Wales College of Medicine, Wales, UK. Richard Tranter, MD Claire
More informationMajor Depression: Screening and Diagnosis in Primary Care
BARRY J. WU, MD, FACP Yale University Major Depression: Screening and Diagnosis in Primary Care Dr Wu is clinical professor of medicine at Yale School of Medicine. He is also associate program director
More informationDepression is a common biological brain disorder and occurs in 7-12% of all individuals over
Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),
More informationMental Health Care Services by Family Physicians (Position Paper)
Background Mental Health Care Services by Family Physicians (Position Paper) Mental health services are an essential element of the health care services continuum. Promotion of mental health and the diagnosis
More informationMajor Depressive Disorders Questions submitted for consideration by workshop participants
Major Depressive Disorders Questions submitted for consideration by workshop participants Prioritizing Comparative Effectiveness Research Questions: PCORI Stakeholder Workshops June 9, 2015 Patient-Centered
More informationImproving the Recognition and Treatment of Bipolar Depression
Handout for the Neuroscience Education Institute (NEI) online activity: Improving the Recognition and Treatment of Bipolar Depression Learning Objectives Apply evidence-based tools that aid in differentiating
More informationDepression Screening in Primary Care
Depression Screening in Primary Care Toni Johnson, MD Kristen Palcisco, BA, MSN, APRN MetroHealth System Our Vision Make Greater Cleveland a healthier place to live and a better place to do business. 2
More informationMajor depression and dysthymic disorder (chronic depression)
MANAGERIAL Long-term Cost Effects of Collaborative Care for Late-life Depression Jürgen Unützer, MD, MPH; Wayne J. Katon, MD; Ming-Yu Fan, PhD; Michael C. Schoenbaum, PhD; Elizabeth H. B. Lin, MD, MPH;
More informationPRACTICE Matters. August, 2004 VOL. 9 ISSUE 2
PRACTICE Matters August, 2004 VOL. 9 ISSUE 2 COLLABORATIVE TREATMENT FOR DEPRESSION Nearly 10% of the population, or about 18.8 million Americans suffer from a depressive disorder at some time in their
More informationAttention-deficit/hyperactivity disorder (ADHD)
5C WHAT WE KNOW ADHD and Coexisting Conditions: Depression Attention-deficit/hyperactivity disorder (ADHD) is a common neurobiological condition affecting 5-8 percent of school age children 1,2,3,4,5,6,7
More informationPresently, there are no means of preventing bipolar disorder. However, there are ways of preventing future episodes: 1
What is bipolar disorder? There are two main types of bipolar illness: bipolar I and bipolar II. In bipolar I, the symptoms include at least one lifetime episode of mania a period of unusually elevated
More informationMental Health. Health Equity Highlight: Women
Mental Health Background A person s ability to carry on productive activities and live a rewarding life is affected not only by physical health but by mental health. In addition, mental well-being can
More informationCounseling for Depression in the Indian Culture. Eastern Illinois University
Counseling for Depression 1 Running Head: COUNSELING FOR DEPRESSION Counseling for Depression in the Indian Culture Eastern Illinois University November, 2003 Counseling for Depression 2 Introduction Psychological
More informationDepression. Information for primary health practitioners. Published by the New Zealand Guidelines Group
Depression Information for primary health practitioners Published by the New Zealand Guidelines Group The National Depression Initiative (NDI) is a campaign to help reduce the impact of depression on the
More informationantidepressants depression in children Should be used to treat and adolescents?
Should antidepressants be used to treat depression in children and adolescents? Key advisor: Dr Sally Merry, Senior lecturer in child and adolescent psychiatry, Werry Centre for Child and Adolescent Mental
More informationFrequently Asked Questions About Prescription Opioids
Mental Health Consequences of Prescription Drug Addictions Opioids, Hypnotics and Benzodiazepines Learning Objectives 1. To review epidemiological data on prescription drug use disorders Ayal Schaffer,
More informationManagement of Adolescent Depression in Health Systems
The Child Study Center at NYU Langone Medical Center Department of Child & Adolescent Psychiatry Management of Adolescent Depression in Health Systems R. Eric Lewandowski, Ph.D. 11/19/2015 Aims / Overview
More informationStep 2: Recognised depression in adults persistent subthreshold depressive symptoms or mild to moderate depression
Step 2: Recognised depression in adults persistent subthreshold depressive symptoms or mild to moderate depression A NICE pathway brings together all NICE guidance, quality standards and materials to support
More informationCLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia
CLINICAL PRACTICE GUIDELINES Treatment of Schizophrenia V. Service Delivery Service Delivery and the Treatment System General Principles 1. All patients should have access to a comprehensive continuum
More informationDefinition of Terms. nn Mental Illness Facts and Statistics
nn Mental Illness Facts and Statistics This section contains a brief overview of facts and statistics about mental illness in Australia as well as information that may be useful in countering common myths.
More informationRECENT epidemiological studies suggest that rates and
0145-6008/03/2708-1368$03.00/0 ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH Vol. 27, No. 8 August 2003 Ethnicity and Psychiatric Comorbidity Among Alcohol- Dependent Persons Who Receive Inpatient Treatment:
More informationplacebo-controlledcontrolled double-blind, blind,
Clinical Potential of Minocycline for Depression with Psychotic Features Tsuyoshi Miyaoka Department of Psychiatry Shimane University School of Medicine Minocycline 1. Second-generation tetracycline which
More information17% Depression A review. ReCent medical news. Epidemiology of depression. The spectrum of depression. July 2015. Did you know?
July 2015 ReCent medical news A response to medical therapy takes at least 2-3 weeks Depression A review Did you know? 17% The lifetime prevalence rate of depression in the US and Western Europe Depression
More informationBipolar Disorders. Poll Question
Bipolar Disorders American Counseling Association DSM-V Webinar Series July 10, 2013 Dr. Todd F. Lewis, Ph.D., LPC, NCC The University of North Carolina at Greensboro Poll Question Who are you? Clinical
More informationDepression Treatment Guide
Depression Treatment Guide DSM V Criteria for Major Depressive Disorders A. Five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous
More informationDepression is one of the most common reasons. By Robin T. Reesal MD, FRCPC, DABPN; and Helen Ewing RN, BN, MN
Focus on CME at the University of Calgary The Art of Managing Depression in Primary Care Depression is a common debilitating disorder that causes significant patient distress and reduced quality of life.
More informationTECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management
TECHNICAL/CLINICAL TOOLS BEST PRACTICE 7: Depression Screening and Management WHY IS THIS IMPORTANT? Depression causes fluctuations in mood, low self esteem and loss of interest or pleasure in normally
More informationHealthy Coping in Diabetes Self Management
Healthy Coping in Diabetes Self Management Support for this product was provided by a grant from the Robert Wood Johnson Foundation in Princeton, New Jersey, 2009 Objectives Describe the relationship among
More informationCLINICAL PRACTICE GUIDELINES. Depression
CLINICAL PRACTICE GUIDELINES Depression MOH Clinical Practice Guidelines 6/2011 3 1 Published by Ministry of Health, Singapore 16 College Road, College of Medicine Building Singapore 169854 Printed by
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationTHE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS
THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS IN MALE PSYCHIATRIC INPATIENTS Bilyana Brdaroska A thesis submitted in accordance with the requirements for the admission to the degree of Doctor of Medicine of
More informationDSM-5 and its use by chemical dependency professionals
+ DSM-5 and its use by chemical dependency professionals Greg Bauer Executive Director Alpine Recovery Services Inc. President Chemical Dependency Professionals Washington State (CDPWS) NAADAC 2014 Annual
More informationAbnormal Psychology PSY-350-TE
Abnormal Psychology PSY-350-TE This TECEP tests the material usually taught in a one-semester course in abnormal psychology. It focuses on the causes of abnormality, the different forms of abnormal behavior,
More informationSuicide in Bipolar Disorder. Julie Anderson, MD Oregon State Hospital Psychiatrist OHSU Assistant Professor September 25, 2012
Suicide in Bipolar Disorder Julie Anderson, MD Oregon State Hospital Psychiatrist OHSU Assistant Professor September 25, 2012 Disclosure Statement I have no significant financial relationships to disclose...
More informationBipolar disorders: Changes from DSM IV TR to DSM 5
Bipolar disorders: Changes from DSM IV TR to DSM 5 M. Amin Esmaeili, MD, MPH Iranian Research Center for HIV/AIDS (IRCHA) Iranian National Center for Addiction Studies (INCAS) Mood disorders committee
More informationComorbid Depression and Alcohol Dependence
Psychiatric Times. Vol. 28 No. 6 SUBSTANCE ABUSE: ADDICTION & RECOVERY Comorbid Depression and Alcohol Dependence New Approaches to Dual Therapy Challenges and Progress By Helen M. Pettinati, PhD and William
More informationClinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder
Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder AACAP Official Action: OUTLINE OF PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS WITH ADHD
More informationUNDERSTANDING CO-OCCURRING DISORDERS. Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015
UNDERSTANDING CO-OCCURRING DISORDERS Frances A. Campbell MSN, PMH CNS-BC, CARN Michael Beatty, LCSW, NCGC-1 Bridge To Hope November 18, 2015 CO-OCCURRING DISORDERS What does it really mean CO-OCCURRING
More informationAntipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease
Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Professional Tool #1: Screening and Monitoring in a High-Risk Population: Questions and Answers Overview of Cardiometabolic
More informationDepression. The treatment and management of depression in adults. This is a partial update of NICE clinical guideline 23
Issue date: October 2009 Depression The treatment and management of depression in adults This is a partial update of NICE clinical guideline 23 NICE clinical guideline 90 Developed by the National Collaborating
More informationAmendments to recommendations concerning venlafaxine
Amendments to recommendations concerning venlafaxine On 31 May 2006 the MHRA issued revised prescribing advice for venlafaxine*. This amendment brings the guideline into line with the new advice but does
More informationDepression often coexists with other chronic conditions
Depression A treatable disease PROPORTION OF PATIENTS WHO ARE DEPRESSED, BY CHRONIC CONDITION Diabetes 33% Parkinson s Disease % Recent Stroke % Hospitalized with Cancer 42% Recent Heart Attack 45% SOURCE:
More informationDepression Remission at Six Months Specifications 2014 (Follow-up Visits for 07/01/2012 to 06/30/2013 Index Contact Dates)
Description Methodology Rationale Measurement Period A measure of the percentage of adults patients who have reached remission at six months (+/- 30 days) after being identified as having an initial PHQ-9
More informationBehavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment
Behavior Therapy Augments Response of Patients With Obsessive-Compulsive Disorder Responding to Drug Treatment Nienke H. Tenneij, Ph.D.; Harold J. G. M. van Megen, M.D.; Damiaan A. J. P. Denys, M.D.; and
More informationNaomi M. Simon, MD, MSc
Generalized Anxiety Disorder and Psychiatric Comorbidities Such as Depression, Bipolar Disorder, and Substance Abuse Naomi M. Simon, MD, MSc Generalized anxiety disorder (GAD) has a high rate of comorbidity
More informationMajor Depression Medication Adherence Tool Kit
Major Depression Medication Adherence Tool Kit Major Depression Medication Adherence Tool Kit One of the keys to successfully managing major depression is medication adherence. VSHP has developed a new
More information